Ahmed Farah
About
Ahmed Farah is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging.
According to data from OpenAlex, Ahmed Farah has authored 22 papers receiving a total of 184 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 14 papers in Surgery and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ahmed Farah's work include Coronary Interventions and Diagnostics (13 papers), Cardiac Imaging and Diagnostics (9 papers) and Cardiac Valve Diseases and Treatments (6 papers). Ahmed Farah is often cited by papers focused on Coronary Interventions and Diagnostics (13 papers), Cardiac Imaging and Diagnostics (9 papers) and Cardiac Valve Diseases and Treatments (6 papers). Ahmed Farah collaborates with scholars based in Germany, Switzerland and Chile. Ahmed Farah's co-authors include Marc‐Alexander Ohlow, Bernward Lauer, Raban Jeger, Nicole Gilgen, Norman Mangner, Daniel Weilenmann, Sven Möbius‐Winkler, Gregor Leibundgut, Bruno Scheller and Jochen Wöhrle and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and European Heart Journal.
In The Last Decade
Ahmed Farah
21 papers receiving 181 citations
Peers
Ahmed Farah
Maki Oi Japan
Catalina A. Parasca Romania
F. Barlocco Italy
Mauro Pennone Italy
Dario Sillano Italy
Marco Contarini Italy
Pierfranco Terrosu Italy
P. Widimsky Czechia
Birgitte Krogsgaard Andersen Denmark
Oleg Krestyaninov Russia
Citations per year, relative to Ahmed Farah Ahmed Farah (= 1×)
peers
Maki Oi
Countries citing papers authored by Ahmed Farah
Since
Specialization
Citations
This map shows the geographic impact of Ahmed Farah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed Farah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed Farah more than expected).
Fields of papers citing papers by Ahmed Farah
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ahmed Farah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed Farah. The network helps show where Ahmed Farah may publish in the future.
Co-authorship network of co-authors of Ahmed Farah
This figure shows the co-authorship network connecting the top 25 collaborators of Ahmed Farah. A scholar is included among the top collaborators of Ahmed Farah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmed Farah. Ahmed Farah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Giménez, María Rubini, Bruno Scheller, Ahmed Farah, et al.. (2023). Sex-specific inequalities in the use of drug-coated balloons for small coronary artery disease: a report from the BASKET-SMALL 2 trial. Clinical Research in Cardiology. 113(7). 959–966.
2.
Seeger, Julia, Jochen Wöhrle, Bruno Scheller, et al.. (2023). Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 Trial. Journal of Cardiovascular Development and Disease. 10(3). 119–119.
3.
Mahfoud, Felix, Ahmed Farah, Marc‐Alexander Ohlow, et al.. (2022). Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial. Clinical Research in Cardiology. 111(7). 806–815.
4.
Scheller, Bruno, Tuomas T. Rissanen, Ahmed Farah, et al.. (2022). Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial. Circulation Cardiovascular Interventions. 15(4). e011569–e011569.
5.
Farah, Ahmed, Mohammed Elgarhy, Marc‐Alexander Ohlow, et al.. (2022). Efficacy and safety of drug-coated balloons according to coronary vessel size. A report from the BASKET-SMALL 2 trial. Advances in Interventional Cardiology. 18(2). 122–130.
6.
Buck, Thomas, et al.. (2021). Recurrence of Functional Versus Organic Mitral Regurgitation After Transcatheter Mitral Valve Repair: Implications from Three-Dimensional Echocardiographic Analysis of Mitral Valve Geometry and Left Ventricular Dilation for a Point of No Return. Journal of the American Society of Echocardiography. 34(7). 744–756.
7.
Wöhrle, Jochen, Bruno Scheller, Julia Seeger, et al.. (2021). Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents. JACC: Cardiovascular Interventions. 14(16). 1789–1798.
8.
Wöhrle, Jochen, Bruno Scheller, Julia Seeger, et al.. (2021). Impact of diabetes on outcome with drug-coated balloons versus drug-eluting stents: the BASKET-SMALL 2 trial. European Heart Journal. 42(Supplement_1).
9.
Fahrni, Gregor, Bruno Scheller, Michael Coslovsky, et al.. (2020). Drug-coated balloon versus drug-eluting stent in small coronary artery lesions: angiographic analysis from the BASKET-SMALL 2 trial. Clinical Research in Cardiology. 109(9). 1114–1124.
10.
Hamed, Motaz, et al.. (2019). Metabolic factors of coronary arteries restenosis formation and unfavourable outcomes prediction of stent angioplasty in patients with chronic coronary heart disease. Archives of Cardiovascular Diseases Supplements. 11(2). 188–189.
11.
Jeger, Raban, Ahmed Farah, Marc‐Alexander Ohlow, et al.. (2018). Drug-Coated Balloons for Small Coronary Artery Disease. SSRN Electronic Journal.
12.
Ohlow, Marc‐Alexander, Ahmed Farah, Thomas Kuntze, & Bernward Lauer. (2018). Patients' preferences for coronary bypass grafting or staged percutaneous coronary intervention in multi-vessel coronary artery disease. International Journal of Clinical Practice. 72(4). e13056–e13056.
13.
Wong, Vincent Wai‐Sun, Ahmed Farah, Hubertus von Korn, et al.. (2015). Patients ≥ 75 years with acute coronary syndrome but without critical epicardial coronary disease: prevalence, characteristics, and outcome.. PubMed. 12(1). 11–6.
14.
Ohlow, Marc‐Alexander, Vincent Wai‐Sun Wong, Michele Brunelli, et al.. (2014). Acute coronary syndrome without critical epicardial coronary disease: prevalence, characteristics, and outcome. The American Journal of Emergency Medicine. 33(2). 150–154.
15.
Ohlow, Marc‐Alexander, et al.. (2013). Incidence of adverse cardiac events 5 years after polymer‐free sirolimus eluting stent implantation: Results from the prospective Bad Berka Yukon Choice™ registry. Catheterization and Cardiovascular Interventions. 84(7). 1080–1086.
16.
Farah, Ahmed, Marc‐Alexander Ohlow, Markus Frommhold, et al.. (2012). A case of Prinzmetal angina diagnosed by Holter monitoring who survived a sudden cardiac death: Case report. Journal of Cardiology Cases. 6(3). e88–e90.
17.
Ohlow, Marc‐Alexander, Hubertus von Korn, Ahmed Farah, et al.. (2012). TCT-601 Real-world experience of the polymer-free rapamycin-eluting YUKON-Choice stent: five-year results from a prospective registry. Journal of the American College of Cardiology. 60(17). B174–B174.
18.
Farah, Ahmed, et al.. (2012). Hypertrophic Obstructive Cardiomyopathy Masked by Tako-Tsubo Syndrome: A Case Report. SHILAP Revista de lepidopterología. 2012. 1–5.
19.
Ohlow, Marc‐Alexander, J. Christoph Geller, Stefan Richter, et al.. (2011). Incidence and predictors of ventricular arrhythmias after ST-segment elevation myocardial infarction. The American Journal of Emergency Medicine. 30(4). 580–586.
20.
Ohlow, Marc‐Alexander, et al.. (2008). Arzt-Patient-Kommunikation in der invasiven Kardiologie. Medizinische Klinik. 103(12). 831–835.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Maki Oi Breakdown of academic impact, for papers by Catalina A. Parasca Breakdown of academic impact, for papers by F. Barlocco Breakdown of academic impact, for papers by Mauro Pennone Breakdown of academic impact, for papers by Dario Sillano Breakdown of academic impact, for papers by Marco Contarini Breakdown of academic impact, for papers by Pierfranco Terrosu Breakdown of academic impact, for papers by P. Widimsky Breakdown of academic impact, for papers by Birgitte Krogsgaard Andersen Breakdown of academic impact, for papers by Oleg Krestyaninov